Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.22.2
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - $ / shares
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common Stock, par value $ 0.001   $ 0.001
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 24,012,169 21,955,984  
Warrants to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 4,359,193 4,522,654  
Options to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 820,990 828,490  
Unvested Restricted Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 18,710,303 16,389,156  
Unvested Restricted Stock Units [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 121,683 215,684